scRNA-seq analysis revealed potential mediators of these effects, including the transcription factor NUPR1, an inhibitor of ferroptosis, whose expression was up-regulated in GBM cells in CSF and tumors of patients with worse survival outcomes. Here, NUPR1 is linked to glioblastoma.